Stone Ridge Asset Management LLC grew its holdings in MEDNAX Inc (NYSE:MD) by 55.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 99,598 shares of the company’s stock after buying an additional 35,464 shares during the period. Stone Ridge Asset Management LLC owned 0.12% of MEDNAX worth $2,513,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund lifted its holdings in MEDNAX by 1.4% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 37,568 shares of the company’s stock worth $948,000 after purchasing an additional 503 shares during the last quarter. 6 Meridian lifted its holdings in MEDNAX by 4.5% during the 2nd quarter. 6 Meridian now owns 13,850 shares of the company’s stock worth $349,000 after purchasing an additional 594 shares during the last quarter. Swiss National Bank lifted its holdings in MEDNAX by 0.4% during the 2nd quarter. Swiss National Bank now owns 163,500 shares of the company’s stock worth $4,125,000 after purchasing an additional 600 shares during the last quarter. Robecosam AG lifted its holdings in MEDNAX by 4.0% during the 2nd quarter. Robecosam AG now owns 17,100 shares of the company’s stock worth $421,000 after purchasing an additional 665 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in MEDNAX by 538.6% during the 1st quarter. Quadrant Capital Group LLC now owns 1,009 shares of the company’s stock worth $26,000 after purchasing an additional 851 shares during the last quarter. 91.93% of the stock is owned by institutional investors.
In other MEDNAX news, Director Michael Fernandez purchased 64,242 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were bought at an average price of $21.68 per share, for a total transaction of $1,392,766.56. Following the purchase, the director now owns 164,530 shares in the company, valued at approximately $3,567,010.40. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 3.40% of the company’s stock.
MEDNAX (NYSE:MD) last announced its quarterly earnings data on Thursday, August 1st. The company reported $0.89 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.11. MEDNAX had a positive return on equity of 9.34% and a negative net margin of 3.53%. The firm had revenue of $868.31 million during the quarter, compared to analysts’ expectations of $868.71 million. During the same period in the previous year, the firm earned $1.07 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year. On average, equities analysts anticipate that MEDNAX Inc will post 3.04 EPS for the current year.
MD has been the subject of several research reports. BMO Capital Markets dropped their price target on MEDNAX from $32.00 to $25.00 and set a “market perform” rating for the company in a report on Monday, August 5th. Mizuho dropped their price target on MEDNAX from $26.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Citigroup set a $36.00 price objective on MEDNAX and gave the company a “buy” rating in a report on Friday, May 3rd. Zacks Investment Research cut MEDNAX from a “hold” rating to a “sell” rating and set a $26.00 price objective for the company. in a report on Wednesday, July 3rd. Finally, UBS Group dropped their price objective on MEDNAX to $20.00 and set a “sell” rating for the company in a report on Wednesday, July 24th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. MEDNAX presently has a consensus rating of “Hold” and an average target price of $32.80.
MEDNAX Company Profile
MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services.
Further Reading: What is quantitative easing?
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.